Skip Navigation


NDT Advance Access originally published online on November 25, 2005
Nephrology Dialysis Transplantation 2006 21(3):651-659; doi:10.1093/ndt/gfi273
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/3/651    most recent
gfi273v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tamagaki, K.
Right arrow Articles by Fukagawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamagaki, K.
Right arrow Articles by Fukagawa, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Experimental Nephrology

Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia

Keiichi Tamagaki1, Qunsheng Yuan2, Hiroyuki Ohkawa3,{dagger}, Ikuo Imazeki3, Yoshiyuki Moriguchi3, Nobuo Imai3, Susumu Sasaki1, Kazuo Takeda1 and Masafumi Fukagawa2

1 Department of Medicine, Division of Hypertension and Nephrology, Kyoto Prefectural University of Medicine, Kyoto, 2 Division of Nephrology and Dialysis Center, Kobe University School of Medicine, Kobe and 3 Product Research Lab, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan

Correspondence and offprint requests to: Masafumi Fukagawa, MD, PhD, FJSIM, FASN, Division of Nephrology and Dialysis Center, Kobe University School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan. Email: fukagawa{at}med.kobe-u.ac.jp

Background. Marked parathyroid hyperplasia with bone diseases and vascular calcification are unsolved issues in dialysis patients. In this study, we made azotemic model rats by adenine feeding and analyzed the development and progression of the abnormalities.

Methods. Renal failure was induced in 8-week-old male Wistar rats by feeding 0.75% adenine-containing diet for 6 weeks. Serum parameters, parathyroid hyperplasia, bone changes and metastatic calcification were examined at 2, 4 and 6 weeks.

Results. Progressive increase of serum creatinine and inorganic phosphate, and decreased levels of serum calcium and 1,25(OH)2D3 were confirmed. Markedly enlarged parathyroid glands and extremely high PTH levels were observed in all adenine-fed rats compared with the control (PTH: 199.3±58.0 vs 10.5±3.0 pmol/l, P<0.01, respectively, at 6 weeks). In cortical bone of the femur, the morphometric parameters showed increased bone resorption with increased fibrosis, whereas in the trabecular bone, bone resorption decreased and bone volume increased with a larger amount of osteoid compared with the control. Metastatic calcification in aorta, coronary artery and other soft tissues were also found in adenine-fed rats.

Conclusions. Uraemic rats made by adenine diet developed severe abnormalities of calcium metabolism in a relatively short period and therefore they may serve as a useful model for the analysis of parathyroid hyperplasia and vascular calcification in chronic renal failure.

Keywords: adenine; calcification; chronic renal failure; hyperparathyroidism; renal osteodystrophy

{dagger}Deceased


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
F. G. Graciolli, K. R. Neves, L. M. dos Reis, R. G. Graciolli, I. L. Noronha, R. M. A. Moyses, and V. Jorgetti
Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1416 - 1421.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Mathew, K. S. Tustison, T. Sugatani, L. R. Chaudhary, L. Rifas, and K. A. Hruska
The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1092 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Drueke, D. Martin, and M. Rodriguez
Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.